Artificial intelligence is here to help us improve the standard of care and quality of life. At Optain we harness the power of AI to open a window to your health through your eyes. Assure+ suite of products help screen for vision-threatening eye diseases like Glaucoma and provide cardiovascular health assessment. #AI #healthcare #digitalhealth
Glaucoma, a group of progressive optic neuropathies, is characterised by the slow degeneration of retinal ganglion cells and their axons. This leads to a distinctive appearance of the optic disc and a corresponding pattern of visual loss. In this article, Dr Yvette Wang delves into major imaging modalities in glaucoma, and the current applications of artificial intelligence available to assist with effective screening and management of this sight-threatening disease...Read More https://lnkd.in/gmjbZbYb #spon #AI #Glaucoma Optain (Australia) Babak Asgari